A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human BIRC5. The Survivin Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
| Réf. B-LABO | BL-RE-085357 |
| Réf. fabricant | 18112658 |
| Gene ID (Entrez) | 332 |
|---|
| Espèces | Human |
|---|
| Pureté | >80% by SDS-PAGE and Coomassie blue staining |
|---|
| Contenu et stockage | Store at -20°C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS and 1M Urea, pH 7.4. |
|---|
| À utiliser avec (application) | Antibody Competition |
|---|
| Alias de gène | API4, apoptosis inhibitor 4, Apoptosis inhibitor survivin, baculoviral IAP repeat-containing 5, Baculoviral IAP Repeat-Containing Protein 5, BIRC5, EPR-1, IAP4, survivin variant 3 alpha |
|---|
| Symbole de gène(s) | BIRC5 |
|---|
| Poids moléculaire | 32 kDa |
|---|
| Quantité | 100 μl |
|---|
| État réglementaire | RUO |
|---|
| Catégorie de recherche | Adaptive Immunity, Angiogenesis, Apoptosis, Astrocyte Markers, Cancer, Growth and Development, Innate Immunity, Mitotic Regulators, Phospho Specific, Stem Cells |
|---|
| Source | E. coli |
|---|
| Réactivité spécifique | This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-54090. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
Une question, une configuration particulière ?
Contactez-nous pour un devis.